Cormorant Asset Management’s Tango Therapeutics TNGX Stock Holding History

Cormorant Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.8M	Buy	+1,425,000	New	+$19.8M	1.5%	20
2023 Q2	–	Sell	-4,116,949	Closed	-$16.3M	–	75
2023 Q1	$16.3M	Hold	4,116,949	–	–	1.07%	26
2022 Q4	$29.8M	Hold	4,116,949	–	–	2%	15
2022 Q3	$14.9M	Sell	4,116,949 -390,894	-9%	-$1.67M	1.04%	33
2022 Q2	$20.4M	Sell	4,507,843 -391,342	-8%	-$2.37M	1.54%	23
2022 Q1	$37.1M	Hold	4,899,185	–	–	2.85%	12
2021 Q4	$53.1M	Buy	4,899,185 +1,000,000	+26%	+$12M	3.16%	9
2021 Q3	$48.8M	Buy	3,899,185 +3,099,185	+387%	+$37.1M	1.98%	15
2021 Q2	$9.1M	Hold	800,000	–	–	0.31%	66
2021 Q1	$8.9M	Hold	800,000	–	–	0.2%	77
2020 Q4	$9.15M	Hold	800,000	–	–	0.22%	69
2020 Q3	$8.37M	Buy	+800,000	New	+$8.17M	0.32%	64

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Cormorant Asset Management's TNGX Position: Q1 2026 in Review

Cormorant Asset Management opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 1,425,000 shares worth $29.8M. The stake represents 1.5% of the portfolio and ranks #20 among its holdings. This is a return to the name: Cormorant Asset Management previously reported a position in TNGX as recently as Q1 2023.

Cormorant Asset Management first reported a position in TNGX in Q3 2020 and has held it in 12 quarters since. The position peaked at $53.1M in Q4 2021. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

Cormorant Asset Management held 1,425,000 shares of Tango Therapeutics worth $29.8M as of Q1 2026.
Tango Therapeutics was a new Cormorant Asset Management position in Q1 2026.
Tango Therapeutics made up 1.5% of Cormorant Asset Management's portfolio in Q1 2026, its #20 holding.
Cormorant Asset Management first reported a position in Tango Therapeutics in Q3 2020 and has held it in 12 quarters since.
Cormorant Asset Management's Tango Therapeutics position peaked at $53.1M in Q4 2021.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Cormorant Asset Management's 13F filing for Q1 2026, filed 15 May 2026.